History of health technology assessment in Belgium

International Journal of Technology Assessment in Health Care

Volumn 25, Issue SUPPL.S1, 2009, Pages 82-87

  Cleemput, Irina ^a,b   Van Wilder, Philippe ^c  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c National Institute for Health and Disability Insurance   (Belgium)

Author keywords

Belgium; Biomedical; Health; Insurance; Reimbursement; Technology assessment

Indexed keywords

BELGIUM; EVIDENCE-BASED MEDICINE; FURTHER DEVELOPMENT; GOOD CLINICAL PRACTICES; HEALTH SERVICES RESEARCH; HEALTH TECHNOLOGY ASSESSMENTS; HEALTHCARE RESOURCES; INTERNATIONAL COLLABORATIONS; LEGAL DOCUMENTS; POLICY DECISIONS; POLICY MAKERS; TECHNOLOGY ASSESSMENTS;

DECISION MAKING; HEALTH; HEALTH CARE; INTERNATIONAL COOPERATION; QUALITY ASSURANCE; RESEARCH; TECHNOLOGICAL FORECASTING; TECHNOLOGY; TOTAL QUALITY MANAGEMENT;

HEALTH INSURANCE;

BELGIUM; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; MEDICAL RESEARCH; QUALITY CONTROL; REIMBURSEMENT; REVIEW;

BELGIUM; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 75149186232     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309090461     Document Type: Review

References (5)

1. Belgian Health Care Knowledge Centre. Programmawet (I) van 24 december 2002, Title III, chapter 2. B.S./M.B. 31-12-2002.
2. Drug Reimbursement Committee. Royal Decree of 21 December 2001 (published 29 December 2001): Koninklijk besluit van 21 december 2001 tot vaststelling van de procedures, termijnen en voorwaarden inzake de tegemoetkoming van de verplichte verzekering voor geneeskundige verzorging en uitkeringen in de kosten van farmaceutische specialiteiten, B.S. 29 december 2001 // Arrêté royal de 21 d́ecembre 2001 fixant les proćedures, d́elais et conditions concernant l'intervention de l'assurance obligatoire soins de sant́e et indemnit́es dans le coût des spé cialités pharmaceutiques, M.B. le 29 d́ecembre 2001.
3. European Union. Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems. OJ No L 40; 1989.
4. European Union. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use. Official Journal L-311, 28/11/2004. 2001. pp. 67-128.
5. Van Wilder PB, Dupont AG. Reimbursement of medicines in Belgium: Role of evidence-based medicine. Acta Clin Belg. 2009;64:120-128.